scispace - formally typeset
C

Cristina Antinozzi

Researcher at Sapienza University of Rome

Publications -  40
Citations -  520

Cristina Antinozzi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 29 publications receiving 325 citations. Previous affiliations of Cristina Antinozzi include Foro Italico University of Rome & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition

TL;DR: The results point to a reduced proficiency of HR repair as a source of sensitivity of ECs to ICL-inducing agents and PARP inhibitor monotherapy, and suggest that pharmacological inhibition of PARP can be exploited to target the stem cell component of the TGCTs (namely ECs) and to enhance the sensitivity of cisplatin-resistantTGCTs to standard treatments.
Journal ArticleDOI

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy

TL;DR: T helper 1 (Th1) type cytokines and chemokines are bioactive mediators in inflammation underling several diseases and co-morbid conditions, such as cardiovascular and metabolic disorders and sildenafil could be a pharmacologic tool to control CXCL10-associated inflammation in diabetic cardiomyopathy.
Journal ArticleDOI

Vitamin D in autoimmune rheumatic diseases: A view inside gender differences.

TL;DR: The main vitamin D immunoregulatory properties are summarized with some sex hormone‐driven immune activities, in females and males immune systems, and Topics onto vitamin D receptor agonists as potential therapeutic agents in rheumatic disease are addressed.
Journal ArticleDOI

Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?

TL;DR: A possible role of exosomes in SSc pathogenesis is indicated and their potential use as diagnostic and prognostic biomarkers, as well as therapeutic tools, are suggested.
Journal ArticleDOI

Association of circulating CXCL10 and CXCL11 with systemic sclerosis.

TL;DR: This study investigated whether the shift from very early diagnosis of SSc (VEDOSS), when vasculopathy and fibrosis are at very low degree, to definite SSc elicits serum CXCL10/CXCL11 modifications.